Home > Boards > US Listed > Medical - Drugs > Revive Therapeutics Ltd. (RVVTF)

BINGO! Unlike remdesivir there is limited information known

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
powerbattles Member Profile
 
Followed By 2,038
Posts 80,586
Boards Moderated 15
Alias Born 09/12/03
160x600 placeholder
powerbattles   Sunday, 08/02/20 09:58:46 AM
Re: Giovanni post# 4790
Post # of 8441 
BINGO! Unlike remdesivir there is limited information known about the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19. Bucillamine, is a medication with a well-established safety. Bucillamine has shown significant potential to reduce lung inflammation damage associated with a serious infection.
IMHO:))) The U.S. Food and Drug Administration will issued an emergency use authorization for the compassionate use with "in a few week time".

Quote:
“We are preparing plans for initiating the Phase 3 study upon the IND becoming active by the U.S. FDA and we look forward to advancing Bucillamine as a potential new treatment option for patients with a confirmed diagnosis of COVID-19 globally.”



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist